human | Q5 |
P227 | GND ID | 124310796 |
P496 | ORCID iD | 0000-0001-6099-7066 |
P2038 | ResearchGate profile ID | Arif_Ekici |
P214 | VIAF ID | 69857964 |
P10832 | WorldCat Entities ID | E39PBJmty3kCHCxyJWH3wvtYfq |
P108 | employer | University of Erlangen–Nuremberg | Q40025 |
P734 | family name | Ekici | Q21510062 |
Ekici | Q21510062 | ||
Ekici | Q21510062 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
Q50795840 | 7 Mb de novo deletion within 8q21 in a patient with distal arthrogryposis type 2B (DA2B). |
Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
Q51710826 | A 15Mb duplication of 6q24.1-q25.3 associated with typical but milder features of the duplication 6q syndrome. |
Q45327377 | A Homozygous Mutation in GPT2 Associated with Nonsyndromic Intellectual Disability in a Consanguineous Family from Costa Rica |
Q64042051 | A biallelic truncating AEBP1 variant causes connective tissue disorder in two siblings |
Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
Q35957063 | A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density |
Q51958807 | A de novo 7.6Mb tandem duplication of 14q32.2-qter associated with primordial short stature with neurosecretory growth hormone dysfunction, distinct facial anomalies and mild developmental delay. |
Q47969037 | A defect of CD16-positive monocytes can occur without disease |
Q33747778 | A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. |
Q29417084 | A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
Q44360476 | A new quantitative PCR multiplex assay for rapid analysis of chromosome 17p11.2-12 duplications and deletions leading to HMSN/HNPP. |
Q34478037 | A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency |
Q33947899 | ABCA transporter gene expression and poor outcome in epithelial ovarian cancer |
Q37227494 | ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas |
Q38435465 | Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease |
Q24615911 | Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature |
Q36831854 | Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome |
Q74395677 | Assay of transfection rate in insect cells on a single cell level |
Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
Q35156876 | Assessment of hepatocyte growth factor in ovarian cancer mortality |
Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
Q37684409 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q33828680 | Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival |
Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
Q41457344 | Association of relative telomere length with cardiovascular disease in a large chronic kidney disease cohort: the GCKD study |
Q42638461 | Associations between genetic risk variants for kidney diseases and kidney disease etiology. |
Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
Q114595153 | Astrogenesis in the murine dentate gyrus is a life‐long and dynamic process |
Q57990746 | BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients |
Q57990749 | Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition |
Q54765023 | Biallelic SEMA3A defects cause a novel type of syndromic short stature. |
Q36284638 | Blunted transcriptional response to skeletal muscle ischemia in rats with chronic kidney disease: potential role for impaired ischemia-induced angiogenesis |
Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
Q37660589 | Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis |
Q34201805 | Breast Cancer Risk - Genes, Environment and Clinics |
Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
Q24315560 | CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila |
Q91325233 | CRISPR/Cas9-Mediated Knock-Out of KrasG12D Mutated Pancreatic Cancer Cell Lines |
Q36419325 | CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer |
Q34793437 | CYP2B6*6 is associated with increased breast cancer risk |
Q28385765 | Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk |
Q40862474 | Characterisation of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORS1. |
Q52562772 | Characterization of germ cell differentiation in the male mouse through single-cell RNA sequencing. |
Q35782435 | Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer |
Q48266850 | Clinical and experimental evidence suggest a link between KIF7 and C5orf42-related ciliopathies through Sonic Hedgehog signaling |
Q73299435 | Clinical and morphological phenotype of HMSN 1A mosaicism |
Q45746480 | Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity |
Q41936251 | Cohen syndrome diagnosis using whole genome arrays |
Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
Q35668946 | Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk |
Q36490507 | Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). |
Q34126314 | Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer |
Q35891162 | Common breast cancer susceptibility loci are associated with triple-negative breast cancer |
Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
Q29417145 | Common variants at 19p13 are associated with susceptibility to ovarian cancer |
Q28943518 | Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis |
Q36255665 | Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q36026731 | Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer |
Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
Q34342248 | Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q101216461 | Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers |
Q28115665 | DYNC2LI1 mutations broaden the clinical spectrum of dynein-2 defects |
Q28283899 | Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome) |
Q57386936 | Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort |
Q38271699 | Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling in humans and mice |
Q64057851 | Dissecting TSC2-mutated renal and hepatic angiomyolipomas in an individual with ARID1B-associated intellectual disability |
Q34215102 | Disturbed Wnt Signalling due to a Mutation in CCDC88C Causes an Autosomal Recessive Non-Syndromic Hydrocephalus with Medial Diverticulum |
Q125929495 | Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases |
Q40481745 | Do telomeres have a higher plasticity than thought? Results from the German Chronic Kidney Disease (GCKD) study as a high-risk population. |
Q35815412 | Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study |
Q24633316 | Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer |
Q36487146 | Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk |
Q57319395 | Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer |
Q57990835 | Erratum: Corrigendum: Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome) |
Q33932856 | Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium |
Q36966218 | Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study |
Q51836646 | Evaluation of conserved and ultra-conserved non-genic sequences in chromosome 15q15-linked periodic catatonia. |
Q39785284 | Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population |
Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q91945714 | Evolutionary conserved networks of human height identify multiple Mendelian causes of short stature |
Q47439347 | Exome Pool-Seq in neurodevelopmental disorders. |
Q21261497 | Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1 |
Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
Q50793443 | Familial short stature due to a 5q22.1-q23.2 duplication refines the 5q duplication spectrum. |
Q33411103 | FcgammaRIIa genotype is associated with acute coronary syndromes as first manifestation of coronary artery disease |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q35063160 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk |
Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q37002930 | Five endometrial cancer risk loci identified through genome-wide association analysis |
Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
Q114182808 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q33698621 | GPFrontend and GPGraphics: graphical analysis tools for genetic association studies |
Q36956156 | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer |
Q33262036 | Gene polymorphisms leading to calcified and stenotic aortic valves |
Q41040904 | Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study |
Q37389405 | Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer |
Q115209620 | Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus |
Q92978186 | Genetic interaction screen for severe neurodevelopmental disorders reveals a functional link between Ube3a and Mef2 in Drosophila melanogaster |
Q54940815 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. |
Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
Q34660068 | Genetic regulation of serum phytosterol levels and risk of coronary artery disease |
Q45968079 | Genetic risk factors for ovarian cancer and their role for endometriosis risk. |
Q40687484 | Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies |
Q42037854 | Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short stature |
Q92784883 | Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans |
Q46721561 | Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study |
Q98949558 | Genetic variants in the glucocorticoid pathway genes and birth weight |
Q48657862 | Genetic variants in the tryptophan hydroxylase 2 gene (TPH2) and depression during and after pregnancy. |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q58765390 | Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease |
Q52726273 | Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms. |
Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
Q36218993 | Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium |
Q58061656 | Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
Q29417135 | Genome-wide association study identifies a common variant associated with risk of endometrial cancer |
Q57083838 | Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23 |
Q36024614 | Genome-wide association study identifies a possible susceptibility locus for endometrial cancer |
Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
Q33778612 | Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. |
Q34514932 | Genome-wide association study with DNA pooling identifies variants at CNTNAP2 associated with pseudoexfoliation syndrome |
Q58273567 | Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype |
Q36916243 | Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer |
Q114182677 | Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis |
Q46188099 | HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics |
Q54682256 | HIBCH deficiency in a patient with phenotypic characteristics of mitochondrial disorders. |
Q99728010 | HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment |
Q46475402 | HOXA10 and HOXA13 sequence variations in human female genital malformations including congenital absence of the uterus and vagina |
Q35843242 | Haploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability |
Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
Q40114353 | Heterologous expression of wildtype and mutant myocilin in High Five insect cells shows comparable effects to cultivated trabecular meshwork cells |
Q47152682 | High resolution chromosomal microarray analysis in paediatric obsessive-compulsive disorder |
Q35406344 | Homozygosity mapping in 64 Syrian consanguineous families with non-specific intellectual disability reveals 11 novel loci and high heterogeneity |
Q47844735 | Hyperandrogenemia and high prolactin in congenital utero-vaginal aplasia patients |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q37006170 | Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. |
Q30252854 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer |
Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
Q36014067 | Identification of novel genetic markers of breast cancer survival |
Q35541663 | Identification of six new susceptibility loci for invasive epithelial ovarian cancer |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q30157102 | Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models |
Q55670527 | Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models |
Q34996647 | Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q93212826 | Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation |
Q52569173 | Integrative bioinformatics analysis characterizing the role of EDC3 in mRNA decay and its association to intellectual disability. |
Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
Q37725393 | Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome |
Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
Q35125879 | Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study |
Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
Q112297535 | Lymphocyte Immune Response and T Cell Differentiation in Fontan Patients with protein-losing enteropathy |
Q63976985 | Macrophage Phosphoproteome Analysis Reveals MINCLE-dependent and -independent Mycobacterial Cord Factor Signaling |
Q98772941 | Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer |
Q36333368 | Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. |
Q37081880 | MicroRNA profiles classify papillary renal cell carcinoma subtypes |
Q33844958 | MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening |
Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
Q38329105 | Molecular differentiation between osteophytic and articular cartilage--clues for a transient and permanent chondrocyte phenotype |
Q37004613 | Molecular karyotyping in patients with mental retardation using 100K single-nucleotide polymorphism arrays |
Q71194984 | Mosaicism for the Charcot-Marie-Tooth disease type 1A duplication suggests somatic reversion |
Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
Q51850375 | Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. |
Q48741684 | Mutations in the BAF-Complex Subunit DPF2 Are Associated with Coffin-Siris Syndrome. |
Q28263536 | Mutations in the pericentrin (PCNT) gene cause primordial dwarfism |
Q52777524 | NDST1 missense mutations in autosomal recessive intellectual disability. |
Q24324062 | NEK1 mutations cause short-rib polydactyly syndrome type majewski |
Q59334977 | Need for high-resolution Genetic Analysis in iPSC: Results and Lessons from the ForIPS Consortium |
Q26799669 | Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk |
Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
Q35620425 | Novel loci for non-syndromic coarctation of the aorta in sporadic and familial cases |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q38964627 | PEDF Is Associated with the Termination of Chondrocyte Phenotype and Catabolism of Cartilage Tissue. |
Q37666339 | Paradoxical antidepressant effects of alcohol are related to acid sphingomyelinase and its control of sphingolipid homeostasis |
Q47808365 | Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele |
Q34209634 | Percent Mammographic Density and Dense Area as Risk Factors for Breast Cancer |
Q34528209 | Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q42985583 | Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy |
Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
Q46158039 | Polymorphisms in estrogen metabolism and estrogen pathway genes and the risk of miscarriage |
Q36915870 | Polymorphisms in inflammation pathway genes and endometrial cancer risk |
Q42013702 | Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients |
Q41011976 | Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q38020274 | Premature osteoarthritis as presenting sign of type II collagenopathy: a case report and literature review |
Q111429975 | Prevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease study |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q112713329 | RNA sequencing reveals induction of specific renal inflammatory pathways in a rat model of malignant hypertension |
Q28275978 | Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study |
Q34629255 | Rare copy number variants are a common cause of short stature |
Q30418097 | Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets |
Q34606561 | Reduced syncytin-1 expression levels in placental syndromes correlates with epigenetic hypermethylation of the ERVW-1 promoter region |
Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
Q70992261 | Regional localization of rat myelin protein zero Mpz gene to chromosome 13q24-25 by means of FISH |
Q53060558 | Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin. |
Q40844837 | Rhinovirus inhibits IL-17A and the downstream immune responses in allergic asthma |
Q27332133 | Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation |
Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
Q37624504 | Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10 |
Q54950358 | Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data. |
Q55013059 | Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics. |
Q24535876 | Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator |
Q52362351 | Single molecule real time sequencing in ADTKD-MUC1 allows complete assembly of the VNTR and exact positioning of causative mutations. |
Q57158637 | Single-cell RNA sequencing of adult mouse testes |
Q45855742 | Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus |
Q40522835 | TALPID3 controls centrosome and cell polarity and the human ortholog KIAA0586 is mutated in Joubert syndrome (JBTS23) |
Q91265575 | TRIM28 haploinsufficiency predisposes to Wilms tumor |
Q48769304 | The 5-HTTLPR polymorphism modulates the influence on environmental stressors on peripartum depression symptoms. |
Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
Q51422854 | The German Chronic Kidney Disease (GCKD) study: design and methods. |
Q34977975 | The Transient Chondrocyte Phenotype in Human Osteophytic Cartilage: A Role of Pigment Epithelium-Derived Factor? |
Q36917100 | The UGT1A6_19_GG genotype is a breast cancer risk factor |
Q59498470 | The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy |
Q64237249 | The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy |
Q57265642 | The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant |
Q46887444 | The proinflammatory effect of C-reactive protein on human endothelial cells depends on the FcγRIIa genotype |
Q35024008 | The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing |
Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
Q24794728 | Tracing myelin protein zero (P0) in vivo by construction of P0-GFP fusion proteins |
Q38945163 | Transcriptome sequencing reveals maelstrom as a novel target gene of the terminal system in the red flour beetle Tribolium castaneum |
Q43215450 | Two naturally occurring variants of the serotonin receptor gene HTR3C are associated with nausea in pregnancy |
Q92994868 | Two truncating variants in FANCC and breast cancer risk |
Q56342454 | Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility |
Q33847791 | Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer |
Q40946856 | Whole exome sequencing reveals a novel de novo FOXC1 mutation in a patient with unrecognized Axenfeld-Rieger syndrome and glaucoma |
Q56334023 | rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology |
Q37017296 | α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy |
Search more.